Real-World Effectiveness of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: A Population-Based Study in South Korea

Author

Kim S and Suh HS

Journal

Value in Health

Project Number

2022;25(suppl1)